deamidation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-15. Anything still debated is marked as such rather than presented as settled.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Peptide backbone with a fatty diacid chain |
| Molecular weight | About 4813 Da | Calculated from the formula |
| Receptor targets | GIP and GLP-1 receptors | Dual agonist activity at both sites |
| Route of administration | Subcutaneous injection | No approved oral form at present |
| Elimination half-life | About 5 days | Supports extended intervals between administrations |
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
== Personal life == Best later claimed that the greatest moment of his life occurred when he met his future wife, Margaret Mahon (1900–1988) following his return. Best married Margaret Hooper Mahon in Toronto in 1924 and they had two sons. Best's eldest son was Charles Alexander Best, a Canadian politician and geneticist. Best is the grandfather of Susan MacTavish Best. His other son, Henry Best was a well-regarded historian who later became president of Laurentian University in Sudbury, Ontario. Best died on March 31, 1978, in Toronto. He is interred in Mount Pleasant Cemetery, Toronto, not far from Sir Frederick Banting.
In contrast, Slavic settlements in southern Ukraine started to appear relatively early during Cuman rule, with the earliest, such as Oleshia, dating back to the 11th century. Early "Proto-Cossack" groups are generally reported to have come into existence within what is now Ukraine prior to the 13th century as the influence of Cumans grew weaker, although some have ascribed their origins to as early as the mid-8th century. Some historians suggest that the Cossack people were descended from East Slavs, Turks, Tatars, Circassians and others who settled or passed through the vast regions. There are archeological indications, according to Turkologists, that Cossacks are descendants of the native Cumans of Ukraine, who had lived there long before the Mongol invasion. Other theories expand upon that assertion to suggest that the first Cossacks were of Turkic origin. For example, according to Serhii Plokhy, the first Cossacks were of Turkic rather than Slavic stock. Christoph Baumer states that Cossack predecessors from the thirteenth century onward were mainly of Turkic stock, but from the sixteenth century the Cossacks were increasingly joined by Slavs such as Russians and Poles, Baltic Lithuanians and people from today's Ukraine, thus becoming a Slav-Tatar ethnic hybrid. The theory is also reflected in the Constitution of Pylyp Orlyk of 1710 and the Hrabianka Chronicle, which claims Khazar origins for the Cossacks. The Khazar origin myth became popular during the rule of Ivan Mazepa, a reaction against the Polish myth of Sarmatism.
Human-to-human transmission of SARS‑CoV‑2 was confirmed on 20 January 2020 during the COVID-19 pandemic. Transmission was initially assumed to occur primarily via respiratory droplets from coughs and sneezes within a range of about 1.8 metres (6 ft). Laser light scattering experiments suggest that speaking is an additional mode of transmission and a far-reaching one, indoors, with little air flow. Other studies have suggested that the virus may be airborne as well, with aerosols potentially being able to transmit the virus. During human-to-human transmission, between 200 and 800 infectious SARS‑CoV‑2 virions are thought to initiate a new infection. If confirmed, aerosol transmission has biosafety implications because a major concern associated with the risk of working with emerging viruses in the laboratory is the generation of aerosols from various laboratory activities which are not immediately recognisable and may affect other scientific personnel. Indirect contact via contaminated surfaces is another possible cause of infection. Preliminary research indicates that the virus may remain viable on plastic (polypropylene) and stainless steel (AISI 304) for up to three days, but it does not survive on cardboard for more than one day or on copper for more than four hours. The virus is inactivated by soap, which destabilises its lipid bilayer. Viral RNA has also been found in stool samples and semen from infected individuals.
== Small molecule drug candidates == The key amino acids of the BSCI peptides required for activity have been identified, and the tripeptide AcNH-Trp-Val-Gln-OH was shown to itself be a BSCI in the low micromolar range. Based on this structure a number of peptide mimetics were designed, including a range of 3-acylaminoglutarimides, with low nanomolar BSCI potencies. The search for increased stability and potency led to the development of 3-acylaminolactams, with picomolar potencies in vitro and high anti-inflammatory activity in vivo. A small molecule member of this class of BSCIs called FX125L, under development by Funxional Therapeutics, has recently completed phase 2 clinical trials.
Sources: en.wikipedia.org
Lipidomics is the large-scale study of pathways and networks of cellular lipids in biological systems. The word "lipidome" is used to describe the complete lipid profile within a cell, tissue, organism, or ecosystem and is a subset of the "metabolome" which also includes other major classes of biological molecules (such as amino acids, sugars, glycolysis & TCA intermediates, and nucleic acids). Lipidomics is a relatively recent research field that has been driven by rapid advances in technologies such as mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, fluorescence spectroscopy, dual polarisation interferometry and computational methods, coupled with the recognition of the role of lipids in many metabolic diseases such as obesity, atherosclerosis, stroke, hypertension and diabetes. This rapidly expanding field complements the huge progress made in genomics and proteomics, all of which constitute the family of systems biology. Lipidomics research involves the identification and quantification of the thousands of cellular lipid molecular species and their interactions with other lipids, proteins, and other metabolites. Investigators in lipidomics examine the structures, functions, interactions, and dynamics of cellular lipids and the changes that occur during perturbation of the system. Han and Gross first defined the field of lipidomics through integrating the specific chemical properties inherent in lipid molecular species with a comprehensive mass spectrometric approach.
== Scholarly career == Kermani majored in Middle Eastern languages and literature, with minors in philosophy and theater studies, at the University of Cologne, Cairo University, and the University of Bonn. During his semester breaks, he worked as an assistant director and later as a dramaturge at the municipal theaters Schauspiel Frankfurt and Theater an der Ruhr. Kermani wrote his master's thesis in 1993 at the University of Bonn (supervisors: Stefan Wild and Monika Gronke) on the persecuted Egyptian Koranic scholar Nasr Hamid Abu Zaid, whom he later met in Cairo and who had a formative impact on Kermani's approach to religious studies. With the support of the Studienstiftung des deutschen Volkes, Kermani wrote a dissertation entitled Gott ist schön (God is Beautiful), again under the supervision of Arabist Stefan Wild and Iranian studies scholar Monika Gronke. Kermani received his doctorate in Middle Eastern languages and literature at the University of Bonn in 1998. In 2006, he completed his postdoctoral dissertation entitled The Terror of God – Attar, Job, and the Metaphysical Revolt. From 2000 to 2003, Kermani held a long-term fellowship at the Wissenschaftskolleg zu Berlin (Institute for Advanced Studies Berlin), where he headed the Modernity and Islam working group. He initiated several international research projects, including the project Jewish and Islamic Hermeneutics as Cultural Criticism. This gave rise to a proposal for a Jewish-Islamic academy in Berlin.
==== Reduced probability of contamination ==== DMF-based workflows, particularly those using a closed configuration with a top-plate ground electrode, have been shown to be less susceptible to outside contamination compared to some conventional laboratory workflows. This can be attributed to minimal user interaction during automated steps, and the fact that the smaller volumes are less exposed to environmental contaminants than larger volumes which would need to be exposed to open air during mixing. Ruan et al. observed minimal contamination from exogenous nonhuman DNA and no cross-contamination between samples while using their DMF-based digital whole genome sequencing system.
== Early life and education == Francisco "Kiko" Tiu Laurel Jr. was born to Francisco Sr. and Bella Tiu Laurel. As a teenager, Laurel was involved in the Frabelle Fishing Company, and became a full-time employee at 20, where he started in the Engineering department before moving into sales and leadership. He did not finish a college degree, saying that he had dropped out at the age of 19 to find a job that would support his first child.
=== Hygiene and absorbent products === Applications in this field include: super water absorbent material (e.g. for incontinence pads material), nanocellulose used together with super absorbent polymers, nanocellulose in tissue, non-woven products or absorbent structures and as antimicrobial films.
Sources: en.wikipedia.org
Health can play a central role in how people live their lives, reflecting the overall condition in which an organism functions properly, both physically and mentally. Good physical health is associated with high energy and the ability to perform everyday activities. Physical illnesses and disabilities can negatively impact well-being by causing pain, limiting mobility, and reducing the capacity to engage in enjoyable or necessary activities. Good mental health is a state of internal equilibrium in which mental capacities function as they should. Mental disorders are associated with some form of psychological impairment: they typically disrupt the equilibrium by causing distress and may limit the activities a person can engage in. Discrimination can amplify the negative effects of socially stigmatized illnesses and disabilities. Despite its general impact, health does not fully determine happiness, and some individuals affected by severe illnesses and disabilities report high levels of subjective well-being. The availability of healthcare services can mitigate negative effects by providing treatments to restore health or manage and alleviate symptoms. Similarly, adopting a healthy lifestyle, like regular physical activity and a balanced diet, is associated with long-term benefits to well-being.
The major surviving part of the walls is visible adjacent to the only remaining gateway under the tower of the Church of St John the Baptist. By the mid-14th century Bristol is considered to have been England's third-largest town (after London and York), with an estimated 15–20,000 inhabitants on the eve of the Black Death of 1348–49. The plague inflicted a prolonged demographic setback, with the population estimated at between 10,000 and 12,000 during the 15th and 16th centuries. One of the first great merchants of Bristol was William Canynge. Born c. 1399, he was five times mayor of the town and twice represented it as an MP. He is said to have owned ten ships and employed over 800 sailors. In later life he became a priest and spent a considerable part of his fortune in rebuilding St Mary Redcliffe church, which had been severely damaged by lightning in 1446.
=== Recombinant human insulin === Recombinant human insulin has almost completely replaced insulin obtained from animal sources (e.g. pigs and cattle) for the treatment of type 1 diabetes. A variety of different recombinant insulin preparations are in widespread use. Recombinant insulin (insulin aspart) is synthesized by inserting the human insulin gene into E. coli or yeast (Saccharomyces cerevisiae), which then produces insulin for human use. Insulin produced by E. coli requires further post translational modifications (e.g. glycosylation) whereas yeasts are able to perform these modifications themselves by virtue of being more complex host organisms. The advantage of recombinant human insulin is after chronic use patients do not develop an immune defence against it the way animal-sourced insulin stimulates the human immune system.
== Post-natal functions of neohormones == After birth, neohormones play a major role in development of mammary glands and their function. Alongside, neohormones have also been measured to be a significant component of breast milk. The so-called lactocrine hypothesis dictates that breast milk does not simply fulfil nutritional requirements but also plays an important role in signaling and development in the neonate. Neohormones are theorised to have specific effects on target organs in the neonate, but more research is needed in this area, and effects have been observed to different extents in different species.
Sources: en.wikipedia.org
It is a synthetic 39-amino-acid peptide that acts on two incretin receptors, the GIP receptor and the GLP-1 receptor. It is given by subcutaneous injection and has a circulating half-life of roughly five days. It is not a small molecule and is not absorbed usefully from the gut in conventional oral form.
Selective agents act on one receptor, while tirzepatide engages both GIP and GLP-1 receptors. The added GIP activity may contribute effects on insulin sensitivity and on fat metabolism. Whether the dual action produces meaningful clinical advantages beyond differences in potency is still being examined.
The downstream consequences of GIP receptor activation are not fully characterised in humans. It is also unclear how much each receptor contributes to appetite reduction and to shifts in body composition. Published work describes associations and proposed pathways rather than settled causal chains.
RP-HPLC is widely used for purity and impurity profiling. Mass spectrometry confirms identity.